Role of Natural Killer Cell Activity in the Pathogenesis of Endometriosis
Defects in natural killer cell cytotoxicity function in eliminating ectopic endometrial cells may promote the development and progression of endometriosis and associated infertility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews published literature on how natural killer (NK) cell activity may contribute to the pathogenesis of endometriosis, emphasizing NK cytotoxic effector function and its ability to lyse target cells in an MHC class I-independent manner. It reports that endometriosis is associated with a defect in NK cell cytotoxicity, which can impair elimination of endometrial cells in ectopic sites, and that altered NK-mediated innate immunity may disturb adaptive immune functions and thereby support disease development and infertility. A key limitation is that the work is explicitly a literature review/summarization rather than a new primary study with original experiments. This paper is centrally about endometriosis — specifically, it reviews how impaired NK cell activity and NK-driven immune dysregulation may underlie endometriosis pathogenesis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
7,933 characters
· extracted from
oa-doi-fallback
· 3 sections
· click to expand
Abstract
Keywords
Abstract
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (50)
- Metabolic remodeling of endometriosis microenvironment: Energy stress and immune evasion 2026
- Deciphering the Diagnostic and Natural Therapeutic Implications of Necrosis by Sodium Overload and NK Signatures in Endometriosis Patients 2026
- Identification of diagnostic markers related to inflammatory response and cellular senescence in endometriosis using machine learning and in vitro experiment 2024
- A new look at the theoretical causes of endometriosis: Narrative review 2024
- Immune pathway through endometriosis to ovarian cancer 2024
- Changes in the number and activity of natural killer cells and its clinical association with endometriosis: systematic review and meta-analysis 2024
- The vicious cycle of chronic endometriosis and depression-an immunological and physiological perspective 2024
- A Preliminary Investigation of the Roles of Endometrial Cells in Endometriosis Development via In Vitro and In Vivo Analyses 2024
- Validation of Contour Extraction Using YOLACT for Analysis of NK Cell Chemotaxis 2023
- Immune and endocrine regulation in endometriosis: what we know 2023
- Similarities in Pathogenetic Mechanisms Underlying the Bidirectional Relationship between Endometriosis and Pelvic Inflammatory Disease 2023
- Pathogenesis of Endometriosis: Role of Platelets in Endometriosis 2022
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- Peritoneal natural killer cell chemotaxis is decreased in women with pelvic endometriosis 2022
- Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications 2022
- Histopathologic evaluation of the inflammatory factors and stromal cells in the endometriosis lesions: A case-control study 2022
- Additional file 7 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 3 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 1 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 8 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 12 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- The role of immune-related redox biology in malignant transformation of endometriosis 2021
- Additional file 12 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 2 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- The pathogenesis of endometriosis: clues from the immunological evidence 2021
- Additional file 11 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 9 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 1 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Role of Th1, Th2, Th17, and regulatory T cells in endometriosis 2021
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
- Additional file 8 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 6 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 3 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 5 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 10 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 4 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 2 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 9 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 7 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 4 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 6 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 10 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Additional file 5 of Cell subtypes and immune dysfunction in peritoneal fluid of endometriosis revealed by single-cell RNA-sequencing 2021
- Association of microbial dynamics with urinary estrogens and estrogen metabolites in patients with endometriosis 2021
- Abdominal wall endometriosis from general surgeon perspective 2020
- Enhanced local and systemic inflammatory cytokine mRNA expression in women with endometriosis evokes compensatory adaptive regulatory mRNA response that mediates immune suppression and impairs cytotoxicity 2020
- Endometriosis Patients Show an Increased M2 Response in the Peritoneal CD14+low/CD68+low Macrophage Subpopulation Coupled with an Increase in the T-helper 2 and T-regulatory Cells 2020
- Endometriosis: What is the Influence of Immune Cells? 2020
- Alteration of systemic and uterine endometrial immune populations in patients with endometriosis 2020
Source provenance
- europepmc
- last seen: 2026-07-26T06:08:39.051465+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:54.825375+00:00
- unpaywall
- last seen: 2026-07-26T06:48:27.953686+00:00